Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests

Sexually Transmitted Diseases
Joseph MonsonegoKari Syrjänen

Abstract

To assess the concordance and performance of 2 different assays in detection of human papillomavirus (HPV) genotypes among women with abnormal Pap smear. A series of 575 women referred for colposcopy due to an abnormal Pap smear were analyzed with the Linear Array HPV Genotyping test detecting 37 HPV types and compared with Hybrid Capture II (HCII) assay for detection of carcinogenic HPV. Histologic outcomes of cervical intraepithelial neoplasia grade 2 (CIN2) or worse (CIN2+) and CIN3+ were the primary endpoints. Clinical performance, including receiver operating characteristics, was determined for both tests. HCII and linear array (LA) were concordant in 88.1% (433/491; 95% CI 85.3%-91.0%), having a substantial agreement with regular kappa (kappa = 0.70, 95% CI 0.62-0.77) and almost perfect agreement with weighted kappa (ICC = 0.82, 95% CI 0.7-0.85). In detecting CIN2+ and CIN3+, LA is 5% and 6% more sensitive but 9.5% and 8.7% less specific than HCII (area under ROC curve; P = 0.317 and P = 0.875, respectively). Performance of HCII and LA does not significantly differ in detecting CIN2+ or CIN3+.

References

Apr 13, 2000·International Journal of Cancer. Journal International Du Cancer·A B MillerM Onsrud
Jan 2, 2003·Journal of the National Cancer Institute·Mark E ShermanMark Schiffman
Jan 9, 2003·Obstetrics and Gynecology·P WalkerUNKNOWN Nomenclature Committee of the International Federation for Cervical Pathology and Colposcopy
Feb 7, 2003·The New England Journal of Medicine·Nubia MuñozUNKNOWN International Agency for Research on Cancer Multicenter Cervical Cancer Study Group
Jul 23, 2003·Archives of Pathology & Laboratory Medicine·Attila T Lörincz, Ralph M Richart
Sep 2, 2003·The Journal of Pathology·Peter J F SnijdersChris J L M Meijer
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Joseph MonsonegoTom Wright
Feb 19, 2004·Journal of the National Cancer Institute·Diane Solomon, Mark Schiffman
Jun 9, 2004·Journal of Clinical Microbiology·S-M KulmalaK Syrjänen
Nov 16, 2004·Journal of Medical Virology·Anil K ChaturvediMichael E Hagensee
Jan 22, 2005·Cancer·Gary W Gill
Apr 16, 2005·The Lancet Oncology·Vincent CoglianoUNKNOWN WHO International Agency for Research on Cancer
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Gary M CliffordJeanne M Pimenta
May 25, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Brian BrestovacGeoffrey R Shellam
Nov 16, 2005·International Journal of Cancer. Journal International Du Cancer·Philip DaviesMatti Hakama
Jan 19, 2006·Journal of the National Cancer Institute·Joy Melnikow, Stephen Birch
Mar 28, 2006·Journal of Virological Methods·Matthew P StevensSepehr N Tabrizi
Apr 6, 2006·International Journal of Cancer. Journal International Du Cancer·Jack CuzickThomas Iftner
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J MonsonegoE Franco
Aug 29, 2006·Gynecologic Oncology·Chris J MeijerPhilip E Castle
Sep 7, 2006·Journal of Clinical Microbiology·Dennis van HamontWillem J G Melchers

❮ Previous
Next ❯

Citations

Oct 26, 2013·BMC Infectious Diseases·Philippe HalfonMaria Luisa Mateos Lindemann
Jun 15, 2010·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Philippe HalfonBernard Blanc
Dec 22, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Philippe HalfonBernard Blanc
Nov 27, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Philippe HalfonMaria Teresa Sandri
Aug 11, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Janel DockterCristina Giachetti
May 29, 2009·Journal of Medical Virology·Matthew P StevensSepehr N Tabrizi
Apr 7, 2009·American Journal of Obstetrics and Gynecology·Sophia BrismarSonia Andersson
Apr 2, 2013·The Cochrane Database of Systematic Reviews·Marc ArbynWalter J Prendiville
May 6, 2009·International Journal of Cancer. Journal International Du Cancer·Xavier VallèsJordi Casabona
May 18, 2017·BMC Infectious Diseases·George KrashiasChristina Christodoulou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.